Hydroxamic acid derivatives as matrix metalloprotease (MMP) inhibitors
A Standard patent application filed on 09 October 1998 credited to Whitlock, Gavin Alistair
;
Dack, Kevin Neil
Details
Application number :
12301
Application type :
Standard
Application status :
CEASED
Under opposition :
No
Proceeding type :
Invention title :
Hydroxamic acid derivatives as matrix metalloprotease (MMP) inhibitors
Inventor :
Whitlock, Gavin Alistair
;
Dack, Kevin Neil
Agent name :
SPRUSON & FERGUSON
Address for service :
GPO Box 3898 SYDNEY NSW 2001
Filing date :
09 October 1998
Associated companies :
Applicant name :
Pfizer Inc.
Applicant address :
235 East 42nd Street New York NY 10017 United States Of America